NextCure, Inc. (NXTC) Misses Q3 EPS by 277c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($3.22), $2.77 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
• Baosheng signs non-binding MOU with 58.com for AI marketing